LMS appoints Ms. Catherine Rommal to risk and patient safety advisory board
October 11 2005 - 9:01AM
PR Newswire (US)
MONTREAL, Oct. 11 /PRNewswire-FirstCall/ -- LMS Medical Systems
(AMEX:LMZ; TSX:LMZ), a healthcare technology company and developer
of the CALM(TM) system (Computer Assisted Labor Management),
announced today the appointment of Ms. Catherine Rommal, RNC,
CPHRM, FASHRM, to the LMS Risk and Patient Safety Advisory Board.
In 2002, Ms. Rommal was awarded the Greatest Contributions to the
Field of Healthcare Risk Management for Lifetime Achievement Award
from the Southern California Association for Healthcare Risk
Management (SCAHRM). She is a consultant and principal of Perinatal
Risk Consulting. Her nursing career extended over various positions
in perinatal care at Long Beach Memorial Medical Center in Long
Beach, California. Subsequently, she assumed responsibility for
risk management education and product development for Farmers
Insurance Group's Healthcare Professional Liability Division. She
has served on the editorial boards of OB/GYN Malpractice Prevention
Newsletter and the Journal of Perinatology. She served on the
ACOG/AWHON task force that developed the original Nursing Practice
Competencies and Educational Guidelines for Antepartum and
Intrapartum Fetal Heart Monitoring. She has published and lectured
extensively on electronic fetal monitoring and risk management
issues in perinatal care. She is currently President of SCAHRM. LMS
risk management tools are based on probabilistic models and
designed to provide clinicians with an objective real-time bedside
means to more clearly and accurately assess clinical conditions,
improve situational awareness and reduce risk in three (3) primary
areas. CALM Curve provides analysis of labor progression to help
clinicians determine whether or not caesarean section is
appropriate for women demonstrating symptoms of slow labour. CALM
Patterns contains specialized algorithms and neural networks that
detect and measure patterns in fetal heart rate recordings. These
events are interpreted using rule-based systems to consistently and
better identify the fetus at risk for brain injury from oxygen
deprivation. CALM ANNi will use probabilistic models to achieve
this objective. CALM Shoulder Screen algorithms estimate the risk
of severe shoulder dystocia based mainly on maternal and fetal
characteristics. "There are several challenges to be met in
obstetrics today: clinical, cultural, situational, and legal. In
the course of her career, Ms. Rommal has had the opportunity to
experience these issues real time and to develop a deep
understanding of how OB solutions must be designed in order to
provide effective responses," said Dr. Emily Hamilton, Vice
President of Medical Research at LMS. "We look forward to her
insight and guidance in bringing LMS solutions to the specialty."
About LMS: LMS Medical Systems is a leader in the application of
advanced mathematical modeling and neural networks for medical use.
The LMS Computer Assisted Labor Management product suite provides
physicians, nursing staff and risk managers with innovative
obstetrical decision support and risk management tools integrated
into robust clinical information systems designed to improve
outcomes and patient care for mothers and their infants during
labor and delivery. This press release contains forward-looking
statements that involve risks and uncertainties, which may cause
actual results to differ materially from the statements made. For
this purpose, any statements that are contained herein that are not
statements of historical fact may be deemed to be forward- looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Without limiting
the foregoing, the words "believes," "anticipates," "plans,"
"intends," "will," "should," "expects," "projects," and similar
expressions are intended to identify forward-looking statements.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause actual results, future
circumstances, or events to differ materially from those projected
in the forward-looking statements. These risks include, but are not
limited to, those associated with the success of research and
development programs, the adequacy, timing, and results of clinical
trials, the regulatory approval process, competition, securing and
maintaining corporate alliances, market acceptance of the Company's
products, the strength of intellectual property, financing
capability, the potential dilutive effects of any financing,
reliance on subcontractors and key personnel, and other risks
detailed from time-to-time in the Company's public disclosure
documents or other filings with the Canadian and U.S. securities
commissions or other securities regulatory bodies. The
forward-looking statements are made as of the date hereof, and the
Company disclaims any intention and has no obligation or
responsibility, except as required by law, to update or revise any
forward- looking statements, whether as a result of new
information, future events, or otherwise. DATASOURCE: LMS MEDICAL
SYSTEMS INC. CONTACT: Andrea Miller, Communications, LMS Medical
Systems Inc., Tel: (514) 488-3461 Ext. 222, Fax: (514) 488-1880,
E-mail , Website: http://www.lmsmedical.com/
Copyright